logo
  • About us
    • The Company in brief
    • Strategy
    • Market
    • Organisation
      • Management
      • Board of Directors
  • Our Drug Projects
    • Science
    • Pipeline
    • Disorders
      • Primary Biliary Cholangitis (PBC)
      • Hepatic Encephalopathy (HE)
  • Investors
    • Financial Reports and Presentations
    • Corporate Governance
      • Extra General Meeting, August 2022
      • Annual General Meeting 2022
    • Calendar
    • Press Releases
  • Media
    • Press Releases
    • Subscribe
  • Contact

Financial Reports and Presentations

All categories
  • Annual reports
2022
  • 2021
  • 2020
  • All years
English
  • English
  • Swedish
  • All languages
2022

Annual Report 2021

Read more
  • Investors
    • Financial Reports and Presentations
    • Corporate Governance
      • Extra General Meeting, August 2022
      • Annual General Meeting 2022
    • Calendar
    • Press Releases

IR contact

Anders Karlsson
Anders Karlsson
Chief Executive Officer
+46 70 - 918 00 10
[email protected]

Subscribe

CONTACT

Anders Karlsson
Chief Executive Officer
Phone +46 70 – 918 00 10
[email protected]

All contacts

VISITING ADDRESS

Karolinska Institutet Science Park
Fogdevreten 2
SE – 171 65 Solna
Sweden

COMPANY INFORMATION

Umecrine Cognition AB
Registered office in UmeƄ
Reg no 556698-3655

  • Cookies
  • Privacy Policy